Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Leukemia × ponatinib × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 10 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 1

Interventions

fludarabine phosphate 2 revumenib 1 ponatinib 1 midostaurin 1 immunotoxin HA22 1 glucarpidase 1 fludarabine 1 Whole-Body Irradiation 1 Tacrolimus 1 Mycophenolic Acid 1 HA 22 1 Cytarabine 1 Cyclophosphamide 1 Cord Blood Stem Cell Transplantation 1 Carboxypeptidases 1 Busulfan 1 Bone Marrow Transplantation 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01549548 2013-03-15

Compassionate Use Ponatinib

OHSU Knight Cancer Institute

No longer available

MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡